A lengthy takeover process ends with German generic drugmaker Stada agreeing to be bought by investment groups Bain Capital and Cinven.
US healthcare giant Johnson & Johnson is to buy biotech company Actelion to access its highly profitable range of medicines for rare diseases.
Britain’s competition watchdog has fined Pfizer a record 98 million euros for radically raising the cost of an epilepsy drug.
The film “La Fille de Brest” – the daughter of Brest – rolls out like an inquiry.
Under mounting pressure, pharmaceutical company Mylan says it will slash the costs of emergency EpiPens for some patients in the US.
Pfizer has outbid Sanofi to buy the US cancer drug company Medivation, thereby acquiring the prostate cancer treatment Xtandi.
Monsanto has rejected an offer worth $62 billion (55.6 billion euros) from Bayer trying to create the world's biggest agricultural supplier.
Germany's Bayer has offered to buy US seeds company Monsanto for $62 billion (55 billion euros) in cash trying to gain the top spot in the fast-consolidating farm supplies industry.
Drug companies are saying No to death row. The latest pharmaceuticals giant to restrict sales of drugs used in lethal injections to US prisons is
The US Treasury has tightened its rules to prevent companies moving abroad to avoid US taxes. The immediate effect has been for the number one
French drugmaker Sanofi has pledged its 2016 earnings will be stable despite declining sales of diabetes and cancer treatments.
A former pharmaceuticals chief, who hiked the price of a life-saving medicine by more than five thousand percent, has refused to testify in front of
Gavi, an alliance committed to saving lives through vaccination, has put up $5 million for future purchases of a vaccine from US drugmaker Merck Sharp & Dohme to help take it through late-stage clinic
A man left brain dead after a clinical trial in France has now died. He was one of dozens of volunteers at a private facility to have tested an
A patient has died after falling into a coma following a medical trial in Rennes, northwest France. Five other people were hospitalised following the
It appears karma may have caught up with US entrepreneur Martin Shkreli, who has been arrested on fraud charges. In 2015 he became the internet’s
A British pharmaceuticals giant has been forced to pull a bestselling product from the shelves in Australia after a court order. Judges ruled Reckitt
A potent mix of Viagra and Botox is on the cards: their makers have agreed the healthcare sector’s biggest ever takeover deal. The transaction to
It’s worth over seven billion dollars – a Californian biotech company that makes drugs aimed at treating cancer, heart disease and neurological
The Irish-based group Allergan is in talks with Pfizer over a possible merger that would unite the US makers of Botox and Viagra – and create the
With an outstanding 1.1. billion euro bill to the pharmaceutical industry, there are fears that Greece could run out of medicine within three
Antibiotics have saved countless lives since the discovery of penicillin in 1928, but their indiscriminate use means some diseases have become
“A significant step in advancing Shire’s strategy to become a leading biotechnology company.” That’s how chief executive Flemming Ornskov described
Botox producer Allergan has accepted a $66 bn takeover bid by Actavis. The deal ends a nine-month pursuit of Allergan by the Canadian company
The pharmaceutical companies Merck and Pfizer have signed a deal to develop and market immunology drugs that target cancer. The two are developing
A global heath expert has cast doubt over frantic attempts to produce a vaccine to combat Ebola. Anne Roemer-Mahler, from the University of
Pharmaceutical firms view Ebola as unprofitable and an issue for “poor people in poor countries”, it’s been claimed. Sridhar Venkatapuram, a
The European Commission has introduced a common logo for online pharmacies, and the technical requirements for ensuring its authenticity. The logo
British government investigators have launched a formal criminal probe into drugmaker GlaxoSmithKline. The move follows bribery claims in China, as